Affordable medicine, reaching every corner of the world. This is the story of India's twelve-year pharmaceutical transformation — from a $14 billion industry to the backbone of global healthcare.
Source: DGCIS India · FY 2025–26 (April 2025 – March 2026)
Act I · The Rise
In FY 2014–15, India exported $13.8 billion worth of pharmaceuticals. Twelve years later, that number has crossed $31 billion — a 124% increase across 487 product lines, reaching more than 200 countries. Not a sudden leap, but a steady climb built on scale, quality, and an unmatched ability to make medicine affordable.
Source: DGCIS India, 487 pharma HS codes, FY 2014–15 to 2025–26
Act II · Quality
India's pharmaceutical story has evolved beyond volume. Finished medicines — formulations and biologicals — now account for 75% of exports, up from a base once dominated by raw ingredients. The world's pharmacy has moved up the value chain.
Act III · Access
From the United States to Solomon Islands, from cancer drugs in Havana to dialysis machines in Palau — India supplies affordable medicine to more than 200 countries. Each market has its own story.
Act III · India's Helping Hand
When earthquakes, floods, or health emergencies strike, India responds — not with commerce, but with aid. Since 2023, India has shipped essential medicines, vaccines, surgical supplies, and medical equipment to 55+ countries through the Ministry of External Affairs Rapid Response Cell.
Earthquake relief medicines to Nepal. Dialysis machines to Pacific island nations. Post-hurricane supplies to the Caribbean. Anti-cancer drugs to Cuba. Essential medicines to conflict-affected communities in Palestine, Syria, and Yemen.
Act IV · Hope
India's pharmaceutical patent filings have surged from 7,158 in 2014 to 18,668 in 2024 — a 160% increase. What began as generics manufacturing is evolving into research-driven innovation. The vaccine breakthrough, the specialty therapeutics pipeline, and the clinical trial ecosystem all signal a fundamental shift.
The Agenda
India's pharmaceutical export transformation was not accidental. It is the product of deliberate policy choices that created a globally competitive ecosystem — from manufacturing incentives to trade agreements.
Explore Deeper
Each profile tells the story of India's pharmaceutical trade with that market — export trends, product mix, category breakdown, and growth trajectory. Built from DGCIS data, FY 2014–15 to 2025–26.
$9.4B · #1
$903M · #2
$751M · #3
$601M · #4
$862M · #5
$634M · #6
$727M · #7
$779M · #8
$749M · #9
$629M · #10
$516M · #11
$427M · #12
$529M · #13
$449M · #14
$374M · #15
$286M · #16
$291M · #17
$289M · #18
$318M · #19
$318M · #20
$450M · #21
$271M · #22
$270M · #23
$302M · #24
$215M · #25
$267M · #26
$247M · #27
$243M · #28
$206M · #29
$127M · #30
$188M · #31
$331M · #32
$256M · #33
$202M · #34
$219M · #35
$177M · #36
$143M · #37
$162M · #38
$126M · #39
$141M · #40
$73.6M · #41
$199M · #42
$106M · #43
$251M · #44
$170M · #45
$66.9M · #46
$156M · #47
$186M · #48
$114M · #49
$80.8M · #50
$93.4M · #51
$70.0M · #52
$120M · #53
$110M · #54
$145M · #55
$90.3M · #56
$236M · #57
$33.4M · #58
$72.0M · #59
$13.7M · #60
$89.1M · #61
$58.5M · #62
$114M · #63
$113M · #64
$134M · #65
$85.1M · #66
$64.6M · #67
$63.9M · #68
$55.2M · #69
$69.2M · #70
$63.4M · #71
$171M · #72
$95.2M · #73
$55.8M · #74
$114M · #75
$71.9M · #76
$58.3M · #77
$89.1M · #78
$47.1M · #79
$19.7M · #80
$60.2M · #81
$55.4M · #82
$92.6M · #83
$45.4M · #84
$109M · #85
$88.1M · #86
$69.1M · #87
$43.4M · #88
$43.8M · #89
$21.9M · #90
$25.1M · #91
$56.2M · #92
$50.8M · #93
$60.0M · #94
$14.2M · #95
$23.5M · #96
$41.0M · #97
$35.2M · #98
$28.7M · #99
$44.3M · #100
$63.9M · #101
$49.0M · #102
$41.4M · #103
$33.8M · #104
$31.3M · #105
$37.7M · #106
$42.2M · #107
$45.7M · #108
$18.7M · #109
$25.1M · #110
$16.3M · #111
$27.1M · #112
$29.4M · #113
$22.2M · #114
$37.9M · #115
$28.9M · #116
$17.9M · #117
$64.9M · #118
$26.8M · #119
$30.2M · #120
$24.1M · #121
$9.1M · #122
$7.6M · #123
$12.2M · #124
$20.3M · #125
$22.9M · #126
$13.1M · #127
$17.9M · #128
$13.8M · #129
$29.0M · #130
$15.1M · #131
$4.2M · #132
$18.1M · #133
$20.0M · #134
$43.1M · #135
$13.8M · #136
$14.6M · #137
$23.2M · #138
$13.5M · #139
$13.6M · #140
$12.2M · #141
$9.7M · #142
$7.6M · #143
$9.2M · #144
$12.2M · #145
$9.3M · #146
$9.0M · #147
$8.6M · #148
$4.4M · #149
$20.7M · #150
$5.7M · #152
$3.3M · #153
$14.4M · #154
$4.4M · #155
$6.7M · #156
$7.7M · #157
$112K · #158
$3.8M · #159
$4.1M · #160
$3.9M · #161
$1.7M · #162
$2.6M · #163
$6.4M · #164
$3.8M · #165
$3.0M · #166
$1.6M · #167
$3.4M · #168
$1.2M · #169
$2.6M · #170
$4.1M · #171
$2.7M · #172
$2.4M · #173
$2.3M · #174
$1.2M · #175
$40K · #176
$2.4M · #177
$1.5M · #178